Form D · Venture Capital Fund
Avego BioScience Capital Fund II, L.P.
Alpharetta, GA · CIK 0002118686
Offering snapshot reported Apr 6, 2026 · SEC filing
- Reported sold
- $60M Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 1, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2026 | Initial | $60,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-579231
The entity in Item 12 will receive a fee for certain investors investing in the Issuer in an amount equal to a percentage of such investors' commitments to the Issuer.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BHA Select Network, LLC | 168883 |
Source: Form D, filed Apr 6, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Avego Bio Science Capital Gp Ii, Llc | Director |
| Alyssa Romano | Executive |
| Balaji Venkataraman | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
100 North Main Street, Suite 301
Alpharetta, GA, 30009
Alpharetta, GA, 30009